General form of registration statement for all companies including face-amount certificate companies

CONSOLIDATED BALANCE SHEETS

v3.21.2
CONSOLIDATED BALANCE SHEETS
Mar. 31, 2021
USD ($)
Current assets:  
Cash and cash equivalents $ 579,000
Prepaid expenses and other current assets 193,000
Total current assets 772,000
Total assets 173,370,000
Current liabilities:  
Total current liabilities 1,476,000
Total liabilities 31,679,000
Commitments and contingencies (Note 16)
Convertible preferred stock; (Series A,A-1, B, and B-1), $0.001 par value; 207,390,039 shares authorized at March 31, 2021 and December 31, 2020; 204,703,793 shares issued and outstanding at March 31, 2021 and December 31, 2020; liquidation preference of $77,100 at March 31, 2021 136,691,000
Stockholders? deficit:  
Additional paid-in capital 20,994,000
Accumulated deficit (15,994,000)
Stockholders? deficit 5,000,000
Total liabilities, convertible preferred stock and stockholders? deficit 173,370,000
Evolv Technologies Holdings Inc [Member]  
Current assets:  
Cash and cash equivalents 22,122,000
Accounts receivable, net 2,338,000
Inventory 3,175,000
Current portion of commission asset 690,000
Prepaid expenses and other current assets 5,007,000
Total current assets 33,332,000
Commission asset, noncurrent 1,993,000
Property and equipment, net 11,386,000
Long-term contract assets 119,000
Total assets 46,830,000
Current liabilities:  
Accounts payable 5,633,000
Accrued expenses and other current liabilities 5,540,000
Current portion of deferred revenue 3,110,000
Current portion of long-term debt 24,515,000
Total current liabilities 38,798,000
Deferred revenue, noncurrent 466,000
Common stock warrant liability 737,000
Derivative liability 9,431,000
Long-term debt, noncurrent 18,424,000
Total liabilities 67,856,000
Commitments and contingencies (Note 16)
Convertible preferred stock; (Series A,A-1, B, and B-1), $0.001 par value; 207,390,039 shares authorized at March 31, 2021 and December 31, 2020; 204,703,793 shares issued and outstanding at March 31, 2021 and December 31, 2020; liquidation preference of $77,100 at March 31, 2021 75,877,000
Stockholders? deficit:  
Common stock, $0.001 par value; 325,991,899 and 305,491,899 shares authorized at March 31, 2021 and December 31, 2020, respectively; 30,182,983 and 26,045,532 shares issued and outstanding at March 31, 2021 and December 31, 2020, respectively 30,000
Additional paid-in capital 10,703,000
Accumulated deficit (107,636,000)
Stockholders? deficit (96,903,000)
Total liabilities, convertible preferred stock and stockholders? deficit $ 46,830,000